Surgery – Miscellaneous – Methods
Reexamination Certificate
1998-06-01
2002-09-03
McDermott, Corrine (Department: 3738)
Surgery
Miscellaneous
Methods
C604S008000
Reexamination Certificate
active
06443158
ABSTRACT:
The following U.S. patent applications are hereby fully incorporated:
U.S. Pat. No. 6,213,126, entitled PERCUTANEOUS ARTERY TO ARTERY BYPASS USING HEART TISSUE AS A PORTION OF A BYPASS CONDUIT, filed on even date herewith and assigned to the same assignee as the present application;
U.S. Pat. No. 6,092,526, entitled PERCUTANEOUS CHAMBER-TO-ARTERY BYPASS, filed on even date herewith and assigned to the same assignee as the present application;
U.S. Pat. No. 6,026,814, entitled SYSTEM AND METHOD FOR PERCUTANEOUS CORONARY ARTERY BYPASS, filed on Mar. 6, 1997 and assigned to the same assignee as the present application;
U.S. Pat. No. 6,035,856, entitled PERCUTANEOUS BYPASS WITH BRANCHING VESSEL, filed on Mar. 6, 1997 and assigned to the same assignee as the present application; and
U.S. Pat. No. 6,155,264, entitled PERCUTANEOUS BYPASS BY TUNNELING THROUGH VESSEL WALL, filed on Mar. 6, 1997 and assigned to the same assignee as the present application.
BACKGROUND OF THE INVENTION
The present invention generally deals with vascular bypass methods. More specifically, the present invention deals with systems for performing percutaneous coronary artery bypass procedures.
Coronary arteries can become partially restricted (stenotic) or completely clogged (occluded) with plaque, thrombus, or the like. This reduces the efficiency of the heart, and can ultimately lead to a heart attack. Thus, a number of different systems and methods have been developed for treating stenotic or occluded coronary arteries.
Two methods which have been developed to treat occlusions and stenosis include balloon angioplasty and pharmacological treatment. However, where the occlusion is quite hard, it can be quite difficult, if not impossible, to cross the occlusion with an angioplasty device. In addition, some coronary stenosis are to diffuse to treat effectively with balloon angioplasty. Unfortunately, such occlusions are not readily susceptible to dissolution with chemicals either. In the past, patients with these types of occlusions have been candidates for open heart surgery to bypass the restrictions.
However, open heart surgery includes a myriad of disadvantages. Open heart surgery typically includes a great deal of postoperative pain. The pain is normally encountered because conventional open heart surgery requires that the sternum be cracked open, which is quite painful. Also, open heart surgery typically involves bypassing the occluded vessel, which, in turn, involves harvesting a vein from another part of the body for use as the bypass graft. One common source for the bypass graft is the saphenous vein which is removed from the leg. Harvesting the saphenous vein requires the surgeon to cut and peel the skin back from an area of the leg which is approximately
18
inches long and which extends upward to the groin area. This can be very traumatic and painful. Further, open heart surgery requires quite a lengthy recovery period which involves an increase hospital stay, and, consequently, greater expense.
Other than the pain and more lengthy hospital stay, open heart surgery involves other disadvantages as well. For example, during open heart surgery, it is common to cool the heart to a point where it stops. The blood from the remainder of the vasculature is then pumped through a pulmonary and cardiac bypass system. Any time the heart is stopped, there is a danger of encountering difficulty in restarting the heart (which is typically accomplished by warming the heart and massaging it). Further, even if the heart is restarted, it sometimes does not return to a correct rhythm. Also, open heart surgery can require the use of a device known as a left ventricular assist device (LVAD) to supplementarily pump blood to relieve the burden on the heart. This allows the heart to heal.
A significant reason that the heart is typically stopped during open heart surgery is that, if it were not stopped, the surgeon would be working in a dynamic environment. In such an environment, the target vessels and tissue to be treated are moving. Further, a system must be employed in such an environment to stop bleeding. Clinical studies indicate that, when blood flow is stopped using clamping devices and blood flow is diverted to a cardiac bypass system, a statistically significant instance of neurological problems caused by blood clotting results. The use of mechanical clamps to stop blood flow, and the use of a mechanical bypass system, results in an approximate six percent instance of neurological problems, such as stroke, memory failure, etc.
Given the difficulties of the techniques discussed above, another approach has been developed which does not require stoppage of the heart or an open chest during execution. This approach is to perform a bypass using a minimally invasive technique by entering the upper chest cavity, through a hole between ribs under visual observation. Such a technique is often referred to as minimally invasive direct coronary artery bypass (MIDCAB) (where the heart is not stopped). or heart port (where the heart is stopped). Such a system which is used to perform a bypass is disclosed in the Sterman et al. U.S. Pat. No. 5,452,733.
SUMMARY OF THE INVENTION
The present invention relates to a system for bypassing a restriction in a parent vessel of a mammal via a venous vessel. In the system of the present invention, an adjacent venous vessel is fluidly coupled to a restricted artery distal of a restriction to provide blood flow through the artery distal of the restriction via the venous vessel.
REFERENCES:
patent: 3667069 (1972-06-01), Blackshear et al.
patent: 4016884 (1977-04-01), Kwan-Gett
patent: 4165747 (1979-08-01), Bermant
patent: 4173981 (1979-11-01), Mortensen
patent: 4190909 (1980-03-01), Ablaza
patent: 4230096 (1980-10-01), Zeff et al.
patent: 4546499 (1985-10-01), Possis et al.
patent: 4562597 (1986-01-01), Possis et al.
patent: 4566453 (1986-01-01), Kumano et al.
patent: 4601718 (1986-07-01), Possis et al.
patent: 4610661 (1986-09-01), Possis et al.
patent: 4667673 (1987-05-01), Li
patent: 4690684 (1987-09-01), McGreevy et al.
patent: 4710192 (1987-12-01), Liotta et al.
patent: 4721109 (1988-01-01), Healey
patent: 4790819 (1988-12-01), Li et al.
patent: 4803984 (1989-02-01), Narayanan et al.
patent: 4808163 (1989-02-01), Laub
patent: 4819640 (1989-04-01), Narayanan et al.
patent: 4827931 (1989-05-01), Longmore
patent: 4907591 (1990-03-01), Vasconcellos et al.
patent: 4911164 (1990-03-01), Roth
patent: 4995857 (1991-02-01), Arnold
patent: 5011469 (1991-04-01), Buckberg et al.
patent: 5037428 (1991-08-01), Picha et al.
patent: 5047039 (1991-09-01), Avant et al.
patent: 5053041 (1991-10-01), Ansari et al.
patent: 5053043 (1991-10-01), Gottesman et al.
patent: 5061245 (1991-10-01), Waldvogel
patent: 5067958 (1991-11-01), Sandhaus
patent: 5080663 (1992-01-01), Mills et al.
patent: 5080664 (1992-01-01), Jain
patent: 5104402 (1992-04-01), Melbin
patent: 5144961 (1992-09-01), Chen et al.
patent: 5222962 (1993-06-01), Burkhart
patent: 5222963 (1993-06-01), Brinkerhoff et al.
patent: 5222971 (1993-06-01), Willard et al.
patent: 5234445 (1993-08-01), Walker et al.
patent: 5254113 (1993-10-01), Wilk
patent: 5281236 (1994-01-01), Bagnato et al.
patent: 5282810 (1994-02-01), Allen et al.
patent: 5287861 (1994-02-01), Wilk
patent: 5308320 (1994-05-01), Safar et al.
patent: 5314436 (1994-05-01), Wilk
patent: 5314472 (1994-05-01), Fontaine
patent: 5323789 (1994-06-01), Berggren et al.
patent: 5330486 (1994-07-01), Wilk
patent: 5370683 (1994-12-01), Fontaine
patent: 5382257 (1995-01-01), Lewis et al.
patent: 5383854 (1995-01-01), Safar et al.
patent: 5383928 (1995-01-01), Scott et al.
patent: 5397345 (1995-03-01), Lazarus
patent: 5403333 (1995-04-01), Kaster et al.
patent: 5409019 (1995-04-01), Wilk
patent: 5425705 (1995-06-01), Evard et al.
patent: 5425739 (1995-06-01), Jessen
patent: 5429144 (1995-07-01), Wilk
patent: 5433700 (1995-07-01), Peters
patent: 5437684 (1995-08-01), Calabrese et al.
patent: 5441507 (1995-08-01), Wilk
patent: 5443497 (1995-08-01), Venbrux
patent: 5447512 (1995-09-01), Wilson et al.
Daniel John M. K.
Harrison Kent D.
Kugler Chad J.
LaFontaine Daniel M.
Barrett Thomas C.
McDermott Corrine
Sci-Med Life Systems, Inc.
Westman Champlin & Kelly P.A.
LandOfFree
Percutaneous coronary artery bypass through a venous vessel does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Percutaneous coronary artery bypass through a venous vessel, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Percutaneous coronary artery bypass through a venous vessel will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2860791